XSHE300980
Market cap379mUSD
Jan 10, Last price
20.64CNY
1D
-0.67%
1Q
23.74%
IPO
-34.33%
Name
Hubei Xiangyuan New Material Technology Inc
Chart & Performance
Profile
Hubei Xiangyuan New Material Technology Inc. engages in the research, development, production, and sale of cross-linked polyolefin and silicone foams in China. It offers irradiation cross-linked polyethylene foam; radiation-cross-linked, semirigid, and closed-cell long sheet foam; chemical crosslinked polyethylene foam; 520 polyolefin foam; polyurethane foam; HFPP foam; silicone foam; and other products. The company's products are used in automotive interior, sports and leisure, packaging and cushioning, medical, air-conditioning, and other fields, as well as in construction materials, electronic materials, toys, pipe insulation and anti-condensation materials, miscellaneous industrial materials, consumer goods, and healthcare products. Hubei Xiangyuan New Material Technology Inc. was founded in 2003 and is headquartered in Hanchuan, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 383,683 2.69% | 373,636 -18.32% | |||||||
Cost of revenue | 291,752 | 305,148 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 91,931 | 68,489 | |||||||
NOPBT Margin | 23.96% | 18.33% | |||||||
Operating Taxes | 6,062 | 3,332 | |||||||
Tax Rate | 6.59% | 4.86% | |||||||
NOPAT | 85,869 | 65,157 | |||||||
Net income | 41,021 -27.61% | 56,665 -35.41% | |||||||
Dividends | (16,221) | (21,569) | |||||||
Dividend yield | 0.64% | 1.14% | |||||||
Proceeds from repurchase of equity | (1,948) | ||||||||
BB yield | 0.08% | ||||||||
Debt | |||||||||
Debt current | 50,046 | 42,069 | |||||||
Long-term debt | 413,114 | 851 | |||||||
Deferred revenue | 26,193 | 26,139 | |||||||
Other long-term liabilities | 1 | ||||||||
Net debt | (35,088) | (338,089) | |||||||
Cash flow | |||||||||
Cash from operating activities | 26,532 | 80,244 | |||||||
CAPEX | (295,554) | ||||||||
Cash from investing activities | (477,978) | 58,724 | |||||||
Cash from financing activities | 442,349 | ||||||||
FCF | (309,543) | 43,611 | |||||||
Balance | |||||||||
Cash | 498,249 | 377,520 | |||||||
Long term investments | 1 | 3,489 | |||||||
Excess cash | 479,064 | 362,327 | |||||||
Stockholders' equity | 401,068 | 409,094 | |||||||
Invested Capital | 1,123,816 | 655,699 | |||||||
ROIC | 9.65% | 10.15% | |||||||
ROCE | 5.99% | 6.66% | |||||||
EV | |||||||||
Common stock shares outstanding | 107,949 | 107,847 | |||||||
Price | 23.46 33.83% | 17.53 -37.79% | |||||||
Market cap | 2,532,480 33.95% | 1,890,559 -37.79% | |||||||
EV | 2,497,392 | 1,552,470 | |||||||
EBITDA | 129,419 | 94,971 | |||||||
EV/EBITDA | 19.30 | 16.35 | |||||||
Interest | 12,643 | 1,290 | |||||||
Interest/NOPBT | 13.75% | 1.88% |